S100A7 and breast carcinoma: The more pronounced S100A7 immunoreactivity of breast carcinoma cells at the IF of adjacent adipose stromal tissues compared with that in the IT region suggests that upregulation of S100A7 could be promoted when carcinoma cells interact with breast ASCs.